CHICAGO, Sept. 30, 2021 /PRNewswire/ -- According to the new market research report "Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-based Assays, Stability Testing, Heavy Metal Testing, Thermal Analysis, Cleaning Validation), End User (Pharmaceutical Companies, CROs) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%.
Browse in-depth TOC on "Healthcare Analytical Testing Services Market"
314 – Tables
52 – Figures
357 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833
The Growth in the market is driven by analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, and rising number of clinical trials.
In this report the global healthcare analytical testing services market is segmented by type, end user, and region.
Based on type, the market is segmented into bioanalytical testing, physical characterization, method development & validation, stability testing, batch-release testing, raw material testing, microbial testing, and environmental monitoring services.
The bioanalytical testing segment holds the highest market share, by type, in the healthcare analytical testing services market, in the forecast period.
In 2020, the bioanalytical testing segment accounted for the largest share of the market. The large share of this segment can be attributed to large share of this segment is mainly attributed to the increasing number of drugs in the biopharmaceutical pipeline and the growing biopharmaceutical industry.
The batch-release testing segment is expected to grow at the highest CAGR, by type, in the forecast period.
The batch-release testing segment is expected to grow at the highest CAGR in the forecast period. The highest growth of this segment can be attributed to necessity of these services to ensure the quality of pharmaceuticals and biopharmaceuticals before release for sale, supply, or export.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=108923833
North America holds the highest market share, by region, in the forecast period
The healthcare analytical testing services market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to hold the highest market share, by region, in the forecast period. The high share of this market is due to the presence of a well-established base of pharmaceutical and biopharmaceutical companies, high investments in the biosimilars & biologics segment, and increasing R&D expenditure.
Prominent players in the healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), PPD, Inc. (US), Element Materials Technology (UK), Thermo Fisher Scientific (US), Pace Analytical Services, LLC. (US), Intertek Group LLC. (UK), Merck KGaA (Germany), Danaher Corporation (US), Source BioScience (UK), Almac Group (UK), ICON plc (Ireland), Frontage Laboratories, Inc. (US), STERIS plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health (US), Medpace Holdings, Inc. (US), Cinven (LGC Limited) (UK), Anacura (Belgium), Impact Analytical (US), & CD BioSciences (US).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=108923833
Browse Adjacent Markets: Analytical and Scientific Instrumentation Market Research Reports & Consulting
Browse Related Reports:
Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Laboratory), Therapeutic Area (Oncology, Infectious Disease), Molecule Type (Vaccine, CGT), End User (Pharma, Biopharma, Research Institute) - Global Forecast to 2026
Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) - Global Forecast to 2025
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/healthcare-analytical-testing-services-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/healthcare-analytical-testing-services.asp